---
layout: minimal-medicine
title: Bortezomib
---

# Bortezomib
### Generic Name
Bortezomib

### Usage

Bortezomib is a medication primarily used to treat multiple myeloma, a type of blood cancer affecting plasma cells in the bone marrow.  It's also approved for treating mantle cell lymphoma, another type of blood cancer.  Beyond these primary uses, bortezomib sees off-label use in various other conditions, including relapsed or refractory (treatment resistant) forms of several lymphomas,  systemic light-chain amyloidosis (a condition where amyloid protein deposits in organs), and even in some cases of antibody-mediated rejection after cardiac transplantation.  However, it's crucial to understand that these off-label uses are not officially approved by regulatory bodies and should only be considered under the strict guidance of a healthcare professional.

### Dosage

Bortezomib dosing is complex and highly variable, depending on the specific condition being treated, the patient's overall health (including liver and kidney function), and whether it's being used alone or in combination with other drugs.  Dosages are usually calculated based on body surface area (BSA) in mg/m².  There are no universally standardized doses; instead, various regimens exist, each with its specific schedule and combinations with other medications (like melphalan, prednisone, dexamethasone, cyclophosphamide, lenalidomide, thalidomide, daratumumab,  or others). 

Bortezomib is administered intravenously (IV) or subcutaneously (SubQ).  The IV route typically involves a rapid push injection.  SubQ administration might be preferred in certain situations, especially for patients at higher risk of peripheral neuropathy (nerve damage). The frequency of administration ranges from twice weekly to once weekly, depending on the treatment protocol.  Children's use is not established, hence there's no pediatric dosage recommendation.  Detailed dosing information must be obtained from a physician or oncologist familiar with the patient’s specific condition and health status.

### Side Effects

Common side effects (occurring in more than 10% of patients) include:

*   Peripheral neuropathy (tingling, numbness, pain in extremities)
*   Fatigue
*   Diarrhea
*   Nausea
*   Constipation
*   Thrombocytopenia (low platelet count)
*   Neutropenia (low neutrophil count)
*   Anemia (low red blood cell count)
*   Skin rash

Less common but potentially serious side effects (can occur in 1-10% or less):

*   Cardiovascular problems (hypotension, heart failure)
*   Severe infections (herpes zoster, pneumonia)
*   Hemorrhage (bleeding)
*   Hepatotoxicity (liver damage)
*   Hypersensitivity reactions
*   Severe peripheral neuropathy

Any new or worsening symptoms should be reported immediately to a healthcare provider.

### How it Works

Bortezomib is a proteasome inhibitor.  Proteasomes are protein complexes inside cells that break down other proteins.  By inhibiting proteasomes, bortezomib prevents the breakdown of certain proteins that would normally be degraded. This build-up of these proteins triggers various processes that ultimately lead to the death of cancerous cells (apoptosis), particularly myeloma and lymphoma cells.

### Precautions

*   **Hypersensitivity:**  Bortezomib is contraindicated in individuals with a known hypersensitivity to it or its components.
*   **Hepatic and Renal Impairment:** Dose adjustments may be necessary for patients with liver or kidney problems.
*   **Pregnancy and Breastfeeding:** Bortezomib is categorized as pregnancy category D, meaning it poses a risk to the developing fetus.  Women of reproductive potential should use effective contraception during treatment and for several months after. Breastfeeding should be avoided.
*   **Drug Interactions:**  Bortezomib can interact with other medications, particularly those that can affect the nervous system, heart, or liver.  Consult a physician about all medications being taken.
*   **Other Precautions:**  Patients should be carefully monitored for side effects, particularly bone marrow suppression, cardiac toxicity, peripheral neuropathy, and infections.  Bortezomib can also affect fertility in both men and women.

### FAQs

*   **Q: How long will I be on bortezomib?**  A: The duration of treatment depends entirely on the specific disease, response to therapy, and the physician's judgment. It can range from several cycles to much longer durations.

*   **Q: Can I take bortezomib with other medications?** A: It's vital to inform your doctor about all other medications, supplements, or herbal remedies you are taking to avoid potential interactions.

*   **Q: How is bortezomib stored?** A:  Storage instructions should be carefully followed as provided by your pharmacist. Generally, it requires refrigeration.

*   **Q: What should I do if I miss a dose?** A:  Do not attempt to make up a missed dose on your own. Contact your doctor or healthcare provider for guidance.

*   **Q: What are the long-term effects of bortezomib?** A:  Long-term effects can vary considerably.  Regular monitoring for persistent or emerging side effects is essential.


**Disclaimer:** This information is intended for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional for diagnosis, treatment, and management of medical conditions.  The dosage and administration information provided here is not exhaustive and should not be used as a substitute for the guidance of a healthcare professional.  Always follow the specific instructions provided by your physician or pharmacist regarding the use of bortezomib.
